In this Q&A, Christopher Brooks, MD, discusses advancing research on intralymphatic immunotherapy for environmental and, more recently, food allergies.
The Ohio State University- Wexner Medical Center
Latest Content
There are plans for a larger sized study testing zetomipzomib in patients with lupus nephritis.
An Ohio State researcher discusses a new medical center education program for navigating addiction risk in pain patients.
Advertisement
Advertisement
Trending on HCPLive
1
FDA Approves Olezarsen (Tryngolza) for Severe Hypertriglyceridemia
2
Delgocitinib Approval Fills a Long-Standing Gap in Chronic Hand Eczema Treatment
3
The Medical Sisterhood: The Strength Nobody Talks About, with Saakshi Khattri, MD
4
Q&A: Cardiometabolic Care Cascade Failure Points, with Rishi Wadhera, MD, MPP, MPhil
5